Origin Healthcare Solutions: TCV makes substantial growth equity investment

NewsGuard 100/100 Score

Origin Healthcare Solutions (“Origin” or the “Company”), an industry leader in healthcare revenue cycle management services and business and clinical intelligence systems, announced that Technology Crossover Ventures (“TCV”) has made a significant growth equity investment in the Company. TCV joins Beecken, Petty & O’Keefe & Company (“BPOC”), an investor since 2006, and management as investors in Origin.

“Origin’s software and services simplify complex business and clinical processes for physician offices. This technology innovation has tremendous growth potential in the office-based physician market, a sector we have actively pursued for some time”

Focused on both office and hospital-based physicians across all medical specialties, Origin supports over 40,000 medical providers nationwide with solutions that offer faster payment and increased collections for medical services rendered, as well as superior business and clinical analytics. Based in Hartford, CT, Origin has grown to 600 employees and over a 1,000 client organizations.

"TCV's extensive knowledge of the healthcare market and successful track record building companies in the information technology and services markets will help us to continue to aggressively invest in maintaining our technology leadership position while expanding our sales and marketing presence," said Jeff Kvam, CEO of Origin. "We look forward to broadening our reach within the physician market and continuing to enhance the revenue collection experience."

As part of the transaction, John Drew, TCV General Partner, will join Origin's Board of Directors. Ken O’Keefe and Grant Patrick from BPOC and Mr. Kvam will remain on the Origin Board.

"Origin’s software and services simplify complex business and clinical processes for physician offices. This technology innovation has tremendous growth potential in the office-based physician market, a sector we have actively pursued for some time,” said John Drew of TCV. "We are excited to partner with BPOC, Jeff, and the rest of the Origin team to further accelerate Origin’s expansion."

“We are thrilled to have TCV as an investor in Origin and look forward to working with TCV and management to fully realize Origin’s potential in this large market,” said Ken O’Keefe of BPOC. “TCV is an ideal partner for Origin at this stage of its development.”

http://www.originhs.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Racial disparities found in delayed COVID-19 testing among healthcare workers